Markus Puhlmann
Direttore Tecnico/Scientifico/R&S presso PERSPECTIVE THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Profilo
Markus Puhlmann is currently the Chief Medical Officer at Perspective Therapeutics, Inc. Prior to his current position, he served as the Head-Global Clinical Development at Seagen Inc. from 2019 to 2022.
Before that, he worked as a Principal at Merck & Co., Inc. from 2015 to 2019.
Dr. Puhlmann holds a doctorate degree from Ludwig-Maximilians-Universität München and an MBA from McDonough School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/04/2024 | 1 375 425 ( 0.20% ) | 2 M $ | 31/05/2024 |
Posizioni attive di Markus Puhlmann
| Società | Posizione | Inizio |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Markus Puhlmann
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2019 |
Formazione di Markus Puhlmann
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Markus Puhlmann
